Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive approach. Proponents often emphasize the potential for substantial therapeutic gains, particularly in diseases where conventional treatments have proven limited. However, this is to assess the considerable financial investment associated with CPI stem cell the